LR

Lesley Russell

Chimeric Therapeutics Limited | Non-Executive Director
Dr Russell has over 25 years' experience and leadership in the international pharmaceutical field as a chief medical officer. She has undertaken clinical development in a number of therapeutic areas including haematology/oncology has had multiple new drug approvals with both FDA and European Medicines Agency (EMA). Dr Russell has extensive experience as a director of NASDAQ listed pharmaceutical companies. She is a member of the Royal College of Physicians UK. She is member of the risk committee.

Companies and Roles

Company
Title
Tenure
Since
CHM
Chimeric Therapeutics Limited
  • Non-Executive Director
4yrs, 2mthAug 2020
IMU
Imugene Limited
  • Non-Executive Director
5yrs, 6mthApr 2019

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMU
Imugene Limited
01/07/2420,488,095500,000838,095N/A
CHM
Chimeric Therapeutics Limited
28/09/23N/AN/A2,750,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMU
Imugene Limited
01/07/24
Issued
250,000$0.055$13,750Conversion of securities
IMU
Imugene Limited
01/07/24
Exercise
250,000$0.055$13,750Conversion of securities
IMU
Imugene Limited
12/01/24
Issued
1,000,000$0.120$120,000Issue of securities
IMU
Imugene Limited
03/10/23
Issued
238,095$0.084$19,999Placement
IMU
Imugene Limited
03/10/23
Issued
238,095$0.047$11,190Placement